K Number
K040192
Device Name
ON-BOARD IMAGER DEVICE
Date Cleared
2004-02-27

(30 days)

Product Code
Regulation Number
892.5050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The On-Board Imager device is used for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation to anatomical and/or fiducial landmarks.
Device Description
PortalVision has been modified to add a kilovoltage xray source and digital imaging system to allow for improved image quality. This additional option will be called the On-Board Imager device and its intended use will be to supplement the PortalVision device or be used as a stand-alone device to allow for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation anatomical and/or fiducial landmarks.
More Information

Not Found

No
The summary describes a hardware modification (adding a kilovoltage x-ray source and digital imaging system) to an existing device for improved image quality and positioning verification. There is no mention of AI, ML, or any related concepts like algorithms for image analysis beyond basic positioning verification.

No
The device is described as an imager for verification of patient position and treatment fields, not for treating a disease or condition.

No

The device is used for verification of patient position and treatment fields, not for diagnosing medical conditions or diseases.

No

The device description explicitly states the addition of a "kilovoltage xray source and digital imaging system," which are hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The On-Board Imager device is used for patient positioning and treatment field verification using kilovoltage X-rays. This is an in vivo process, meaning it involves imaging the patient directly, not analyzing samples taken from the patient.
  • Intended Use: The intended use clearly states "verification of correct patient position" and "verification of the treatment fields," which are related to radiation therapy procedures performed on the patient.

Therefore, the function and intended use of this device fall outside the scope of in vitro diagnostics.

N/A

Intended Use / Indications for Use

The On-Board Imager device is used for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation to anatomical and/or fiducial landmarks.

Product codes

90 IYE

Device Description

PortalVision has been modified to add a kilovoltage xray source and digital imaging system to allow for improved image quality. This additional option will be called the On-Board Imager device and its intended use will be to supplement the PortalVision device or be used as a stand-alone device to allow for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation anatomical and/or fiducial landmarks.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

kilovoltage xray

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

K003636, K032996

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.5050 Medical charged-particle radiation therapy system.

(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

Ko 40192

510(k) Summary

The following information is provided following the format of 21 CFR 807.92 for the On-Board Imager Device.

  1. Submitter: Varian Medical Systems 3100 Hansen Way M/S H055 Palo Alto, CA 94304-1129 Contact Name: Vy Tran Phone: (650) 424-5731 Fax: (650) 842-5040 Email: vy.tran@varian.com Date summary was prepared: January 27, 2004
2.Name of the Device:On-Board Imager
Trade/Proprietary Name:On-Board Imager Device
Common or Usual Name:Imaging Accessory to Medical Linear Accelerator
Classification Name:Medical Charged Particle Radiation Therapy
System
21 CFR §892.5050
Class II
Product Code: 90 IYE
    1. Predicate Devices to claim substantial equivalence:
    • a. Varian Medical Systems'PortalVision, K003636
    • b. Elekta Synergy, K032996
    1. Description of the Device: PortalVision has been modified to add a kilovoltage xray source and digital imaging system to allow for improved image quality. This additional option will be called the On-Board Imager device and its intended use will be to supplement the PortalVision device or be used as a stand-alone device to allow for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation anatomical and/or fiducial landmarks.
    1. Intended Use Statement: The On-Board Imager device is used for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation to anatomical and/or fiducial landmarks.
    1. Summary of the Technological Characteristics: The Substantial Equivalence Comparison Chart provides a comparison of the technological characteristics to those of the predicate devices. This chart is located in Tab 8 of the submission.

1

Image /page/1/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle with three lines representing its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN" are arranged in a circular pattern around the left side of the eagle. The word "USA" is on the right side of the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

FEB 2 7 2004

Ms. Vy Tran Corporate Director, Regulatory Affairs Varian Medical Systems, Inc. 3100 Hansen Way. PALO ALTO CA 94304-1038

Re: K040192

Trade/Device Name: On-Board Imager Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: II Product Code: 90 IYE

Dated: January 27, 2004 Received: January 28, 2004

Dear Ms. Tran:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050,

2

Page 2

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:

8xx.1xxx(301) 594-4591
876.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4616
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx(301) 594-4616
892.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4654
Other(301) 594-4692

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours.

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Indications for Use

510(k) Number (if known): K040192

Device Name: On-Board Imager

Indications for Use:

The On-Board Imager device is used for verification of correct patient position in relation to isocenter and verification of the treatment fields in relation to anatomical and/or fiducial landmarks.

Prescription Use × (Part 21 CFR 801 Subpart D)

.

Over-The-Counter Use (21 CFR 807 Subpart C)

AND/OR

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Nancy brogdon
(Division Sign-Off)

Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K040192